Last $106.84 USD
Change Today -0.87 / -0.81%
Volume 197.3K
CHE On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

chemed corp (CHE) Snapshot

Open
$108.71
Previous Close
$107.71
Day High
$108.71
Day Low
$106.57
52 Week High
11/28/14 - $111.98
52 Week Low
02/5/14 - $72.50
Market Cap
1.8B
Average Volume 10 Days
154.3K
EPS TTM
$5.28
Shares Outstanding
17.0M
EX-Date
11/13/14
P/E TM
20.3x
Dividend
$0.88
Dividend Yield
0.79%
Current Stock Chart for CHEMED CORP (CHE)

chemed corp (CHE) Related Businessweek News

View More BusinessWeek News

chemed corp (CHE) Details

Chemed Corporation provides hospice and palliative care services in the United States. It operates in two segments, VITAS and Roto-Rooter. The company offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. It also provides plumbing and drain cleaning services to residential and commercial customers. Chemed Corporation was founded in 1970 and is based in Cincinnati, Ohio.

13,952 Employees
Last Reported Date: 02/27/14
Founded in 1970

chemed corp (CHE) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $857.9K
Executive Vice President and Chief Executive ...
Total Annual Compensation: $610.5K
Executive Vice President, Chairman of Roto-Ro...
Total Annual Compensation: $314.4K
Principal Accounting Officer, Vice President ...
Total Annual Compensation: $237.7K
Compensation as of Fiscal Year 2013.

chemed corp (CHE) Key Developments

Chemed Corp. Presents at Oppenheimer 25th Annual Healthcare Conference, Dec-10-2014 08:00 AM

Chemed Corp. Presents at Oppenheimer 25th Annual Healthcare Conference, Dec-10-2014 08:00 AM. Venue: The Crowne Plaza Hotel, New York, New York, United States.

Chemed Corp. Declares Quarterly Cash Dividend, Payable on December 8, 2014

Chemed Corporation announced that the Board of Directors has declared a quarterly cash dividend of 22 cents per share on the Company's capital stock, payable on December 8, 2014, to shareholders of record as of November 17, 2014.

Chemed Corporation Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Provides Earnings Guidance for the Full-Year 2014

Chemed Corporation reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company's service revenues and sales was $358,389,000 compared to $340,886,000 a year ago. Income from operations was $40,211,000 compared to $29,210,000 a year ago. Income before income tax was $39,936,000 compared to $25,620,000 a year ago. Net income was $24,585,000 or $1.39 per diluted share, compared to $17,432,000 or $0.94 per diluted share a year ago. Adjusted net income was $26,058,000 or $1.48 per diluted share, compared to $25,098,000 or $1.36 per diluted share a year ago. For the nine months, the company's service revenues and sales was $1,076,871,000 compared to $1,064,725,000 a year ago. Income from operations was $118,382,000 compared to $93,954,000 a year ago. Income before income tax was $113,435,000 compared to $85,975,000 a year ago. Net income was $69,522,000 or $3.87 per diluted share, compared to $54,318,000 or $2.89 per diluted share a year ago. Adjusted net income was $76,351,000 or $4.28 per diluted share, compared to $78,470,000 or $4.17 per diluted share a year ago. Net cash provided by operating activities was $51,009,000 compared to $135,858,000 a year ago. Capital expenditure was $31,745,000 compared to $18,887,000 a year ago. Management estimates that full-year 2014 earnings per diluted share, excluding non-cash expense for stock options, the non-cash interest expense related to the accounting for convertible debt, litigation and other discrete items, will be in the range of $6.00 to $6.05. This compares to 2013 reported adjusted earnings per diluted share of $5.62.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CHE:US $106.84 USD -0.87

CHE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amedisys Inc $27.88 USD +0.21
CONMED Corp $44.05 USD +0.77
Gentiva Health Services Inc $19.15 USD +0.10
Integra LifeSciences Holdings Corp $52.49 USD +0.95
West Pharmaceutical Services Inc $55.08 USD +0.89
View Industry Companies
 

Industry Analysis

CHE

Industry Average

Valuation CHE Industry Range
Price/Earnings 20.9x
Price/Sales 1.3x
Price/Book 4.2x
Price/Cash Flow 14.7x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHEMED CORP, please visit www.chemed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.